FDA 483 - Friese, David - November 02, 2021

During an inspection, David Friese was cited for administering a prohibited drug, sulfamenthazine, in an extralabel manner to lactating dairy cattle. Additionally, the firm failed to maintain adequate treatment records for animals, specifically lacking details on treated animals, dates, drugs, dosages, and withdrawal dates. These observations indicate significant deficiencies in animal drug management and record-keeping practices.